COHANCE LIFESCIENCES LTD — Quarterly Results & Earnings

₹301.45

-1.13%

Profit Growth YoY-46.50%Latest quarter

Sales Growth YoY-7.98%Latest quarter

Sales CAGR 5Y7.51%5 year compound

Profit CAGR 5Y-5.33%5 year compound

📋

Quarterly Performance

YoY Profit Growth-46.50%

🔴 Significant decline

YoY Sales Growth-7.98%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

40.21%

EPS Growth 5Y

-5.33%

Interest Coverage

Higher = safer debt servicing

14.48

ROE

12.67%

ROCE

14.89%

💡

Growth Analysis

COHANCE LIFESCIENCES LTD reported YoY profit growth of -46.50% and revenue growth of -7.98% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 7.51% and profits at -5.33% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on COHANCE LIFESCIENCES LTD

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.